Navigation Links
Intarcia Therapeutics Appoints Gino Santini To Its Board Of Directors
Date:7/26/2013

nded periods of time.

Data from Intarcia's ITCA 650 Phase 2 program have demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI adverse events typically associated with the self-injection products in this class. ITCA 650 is an investigational new therapy and is not currently approved by any regulatory authority. Exenatide, the active agent in ITCA 650, is a glucagon-like peptide-1 (GLP-1) receptor agonist currently marketed globally as twice-daily and once-weekly self-injection therapies for type 2 diabetes. Upon approval, ITCA 650 would represent the first injection-free GLP-1 therapy that can deliver a full year of treatment from a single minipump placement. Intarcia's robust intellectual property portfolio protects ITCA 650 through 2031.

About Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapies to enhance treatment outcomes by optimizing and improving the efficacy, continuous administration and tolerability of drug therapies. In addition, delivering medicines just once or twice yearly virtually ensures patient adherence and compliance, which is very poor in most chronic diseases. Intarcia's drug development expertise and competitive edge are demonstrated by its abilities to stabilize proteins and peptides at above-body temperature and to deliver them in a constant and consistent manner via Intarcia's proprietary technology platform. Intarcia is pursuing a Phase 3-stage development program for type 2 diabetes and has additional programs ongoing for weight regulation to control obesity. For more information on the Company, please visit www.intarcia.com.

Intarcia and its logo are registered trademarks of Intarcia Therapeutics, Inc.


'/>"/>
SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
6. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
7. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
8. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
9. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
10. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... , España, July 4, 2015 ... a la quimioterapia de primera línea para pacientes ... hígado (mCRC) extiende la supervivencia libre de progresión ... cáncer colorrectal metastásico no resecable (mCRC) que se ... mejora en la supervivencia libre de progresión (PFS) ...
(Date:7/3/2015)... , July 4, 2015 ... cible les épidémies que sont l,hypertension, le diabète ... du Sud-Est, par l,intermédiaire de plateformes éducatives gratuites ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) ... charge le diabète en ligne , Prendre ...
(Date:7/3/2015)... Un fournisseur mondial de ... l,hypertension, le diabète et les troubles thyroïdiens en ... et d,une conférence majeure dédiée à ces maladies. ... , Les formations Prendre en ... en charge l,hypertension en ligne et ...
Breaking Medicine Technology:El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 2El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 3El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 4El Congreso Mundial del Cáncer Gastrointestinal presenta nuevos datos del estudio SIRFLOX 5Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3
... 2011 /PRNewswire-iReach/ -- The Institute of ... Maryland Campus from the Accrediting Bureau of Health Education ... ABHES is recognized by the United States Secretary of ... the United States offering predominantly allied health education programs ...
... Oct. 11, 2011, the FDA approved a labeling supplement for ... the FLEXX trial, as well as, 52-week safety data to ... The FLEXX trial was a 26-week multicenter, randomized, double-blind study ... in patients with painful osteoarthritis of the knee. Patients received ...
Cached Medicine Technology:Institute of Health Sciences Receives ABHES Institutional Accreditation for Long Distance Education 2FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA® 2FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA® 3
(Date:7/5/2015)... ... ... Doctors at the Swedish Cancer Institute in Seattle, Washington say with careful ... for people with pleural mesothelioma. Surviving Mesothelioma has just posted the full story. ... patients treated with 25Gy of radiation over five days just prior to surgery had ...
(Date:7/4/2015)... ... July 04, 2015 , ... Chronic Neck Pain. Neck pain ... pain located in the neck. Another 19% suffer from head, migraine, or facial pain, ... that 45% of American workers must deal with neck pain. Strategies for ...
(Date:7/3/2015)... ... ... Harvest Hope Food Bank will hopefully be getting a large donation of canned ... area of Greenville SC are making it their mission to collect as many canned items ... for donations from the public as well. As part of the canned food drive, these ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... its 2015 Annual Conference , the premiere continuing education and networking ... Orlando at SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national president recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
Breaking Medicine News(10 mins):Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:New Advancement in Treatment of Chronic Neck Pain 2Health News:New Advancement in Treatment of Chronic Neck Pain 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3
... Hope,s Call Two-Year Campaign Has Raised Approximately ... and Their Families, BURBANK, Calif., March 1 ... donation to PADRES Contra El Cancer (PADRES) national,spokeswoman Eva ... organization committed to improving the quality of life for,Latino ...
... dropped organs not just a function of age, study reports ... in the United States have one or more pelvic floor ... says a Kaiser Permanente study. , Frequent urge to urinate, ... such disorders. , The study of 4,000 women (80 percent ...
... hospital provider and the state,s largest healthcare,workers, union ... Both parties are eager to get this ... to improve patient care and expand access to,quality ... Healthcare,West (CHW) and SEIU locals United Healthcare Workers-West ...
... Feb. 29 The California,Academy of Physician Assistants (CAPA) ... woman elected as Speaker of the,California State Assembly. Bass, ... 1990, is a former faculty member at the,University of ... to the California Assembly in 2004., As a ...
... following is a,statement by Lorie A. Chaiten, Director, ... We are thrilled with today,s ruling by ... Illinois Parental Notice of Abortion Act of 1995,remains ... most young women in Illinois will consult with ...
... IRVINE, Calif., Feb. 29 Cardiogenesis,Corporation (Pink Sheets: ... used in angina-relieving procedures, today announced that,it will ... for the,fourth quarter and full year ended December ... was previously scheduled for Tuesday, March 4,2008., ...
Cached Medicine News:Health News:National Spokeswoman Eva Longoria Parker to Accept $200,000 Donation From AT&T to Benefit PADRES Contra El Cancer 2Health News:National Spokeswoman Eva Longoria Parker to Accept $200,000 Donation From AT&T to Benefit PADRES Contra El Cancer 3Health News:National Spokeswoman Eva Longoria Parker to Accept $200,000 Donation From AT&T to Benefit PADRES Contra El Cancer 4Health News:Pelvic Floor Disorders Affect 1 in 3 Women 2Health News:UPDATED: Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers 2Health News:UPDATED: Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers 3Health News:Physician Assistant Karen Bass Elected Speaker Elect of California State Assembly 2Health News:Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call 2
Steerable catheter that is ideal for mapping unusual anatomy...
... NAVI-STAR catheter is specifically designed for use ... precision EP deflectable NAVI-STAR catheter houses a ... to indicate, in real time, exact location ... collecting local electrogram information. The NAVI-STAR electro-anatomical ...
... electrodes which are spaced to permit pacing ... in the Right Atrium, the catheter paces ... catheter may then be repositioned to the ... ventricular pacing and recording. If indicated, the ...
For Atrial Mapping. Biosense Webster offers a complete line of specialty 20-pole catheters. The CRISTA CATH 20-pole deflectable catheter is designed for positioning along the crista terminals....
Medicine Products: